Evidence map›Paper›PMID 27033522›Full record

ArticleBiochimica et biophysica acta2016

Phosphatidylethanolamine binding protein 4 (PEBP4) is a secreted protein and has multiple functions.

Huan He, Dan Liu, Hui Lin, Shanshan Jiang, Ying Ying, Shao Chun, Haiteng Deng, Joseph Zaia, Rong Wen, Zhijun Luo

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Frontiers in cellular and infection microbiology · 2026
    Article
  2. Review
  3. Characterization of PEBP-like Genes and Function ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  4. Article
  5. InvestigatingMicrobiology spectrum · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Huan HeGraduate Program of Internal Medicine, Nanchang University Jiangxi Medical College, Nanchang, China; Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118, United States.
Dan LiuDepartment of Biochemistry, Boston University School of Medicine, Boston, MA 02118, United States; Department of Pharmacology, Nanchang University School of Pharmaceutic Sciences, Nanchang, China.
Hui LinGraduate Program of Internal Medicine, Nanchang University Jiangxi Medical College, Nanchang, China; Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118, United States.
Shanshan JiangGraduate Program of Internal Medicine, Nanchang University Jiangxi Medical College, Nanchang, China; Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118, United States; Department of Pharmacology, Nanchang University School of Pharmaceutic Sciences, Nanchang, China.
Ying YingGraduate Program of Internal Medicine, Nanchang University Jiangxi Medical College, Nanchang, China; Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118, United States; Department of Pathology, Institute of Basic Medical Sciences, Nanchang University Jiangxi Medical College, Nanchang, China.
Shao ChunDepartment of Biochemistry, Boston University School of Medicine, Boston, MA 02118, United States.
Haiteng DengMOE Key Laboratory of Bioinformatics, School of Life Sciences, Tsinghua University, Beijing, China.
Joseph ZaiaDepartment of Biochemistry, Boston University School of Medicine, Boston, MA 02118, United States.
Rong WenBascom Palmer Eye Institute, University of Miami Miller Medical School, Miami, FL 33136, United States.
Zhijun LuoDepartment of Biochemistry, Boston University School of Medicine, Boston, MA 02118, United States; Department of Pathology, Institute of Basic Medical Sciences, Nanchang University Jiangxi Medical College, Nanchang, China. Electronic address: zluo@bu.edu.
Boston University · USTsinghua University · CNUniversity of Miami · US

Funding

Mass Spectrometry Resource for Biology and MedicineP41GM104603 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COSTELLO, CATHERINE E. · 2012 to 2017
$10.4M
AMPK regulates angiogenesis by inhibition of the ALK1 signaling pathwayR21EY024388 · NEI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LUO, ZHIJUN · 2014 to 2015
$446k
NEI NIH HHS R21 EY024388NEI NIH HHS R21EY024388NIGMS NIH HHS P41 GM104603
6 · The paper itself

Abstract

Phosphatidylethanolamine binding proteins (PEBP) represent a superfamily of proteins that are conserved from bacteria to humans. In mammals, four members have been identified, PEBP1-4. To determine the functional differences among PEBP1-4 and the underlying mechanism for their actions, we performed a sequence alignment and found that PEBP4 contains a signal peptide and potential glycosylation sites, whereas PEBP1-3 are intracellular proteins. To test if PEBP4 is secreted, we made constructs with Myc epitope at the amino (N) terminus or carboxyl (C) terminus to mask the signal sequence or keep it free, respectively. Our data revealed that both mouse and human PEBP4 were secreted when the epitope was tagged at their C-terminus. To our surprise, secretion was dependent upon the C-terminal conserved domain in addition to the N-terminal signal sequence. When the epitope was placed to the N-terminus, the recombinant protein failed to secrete and instead, was retained in the cytoplasm. Mass spectrometry detected asparagine (N)-glycosylation on the secreted PEBP4. Although overexpression of N-terminal tagged PEBP4 resulted in an inhibition of ERK activation by EGF, that with a C-terminal epitope tag did not have such an effect. Likewise, transfection of PEBP4 shRNA did not appear to affect ERK activation, suggesting that PEBP4 does not participate in the regulation of this pathway. In contrast, PEBP4 siRNA suppressed phosphorylation of Act at S473. Therefore, our results suggest that PEBP4 is a multifunctional protein and can be secreted. It will be important to investigate the mechanism by which PEBP4 is secreted and regulates cellular events.

Indexed as

Amino Acid SequenceEnzyme ActivationExtracellular Signal-Regulated MAP KinasesGlycosylationHEK293 CellsHumansMolecular Sequence DataPhosphatidylethanolamine Binding ProteinPhosphorylationProtein Processing, Post-TranslationalProtein Sorting SignalsProteomicsProto-Oncogene Proteins c-aktRNA InterferenceSequence AlignmentSequence Analysis, ProteinExtracellular Signal-Regulated MAP KinasesPE-binding protein 4, humanPEBP4 protein, mousePhosphatidylethanolamine Binding ProteinProtein Sorting SignalsProto-Oncogene Proteins c-aktActERKGlycosylationPEBP4SecretionSignal peptide

Identifiers

PMID27033522
PMCPMC5336313
OpenAlexW2333015022

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.